LY3972406

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3972406, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]